Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05674370 · ClinicalTrials.gov registry record · NA
A Study of the GRIP Influenza and SARS-CoV-2 POC Assays
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05674370: Completed NA study, sponsored by Mayo Clinic.
NCT05674370 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05674370, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this research is to determine if the use of a new device can accurately detect a virus infection.
Interventions
- DEVICE GRIP Electronic Diagnostic Chip
- DIAGNOSTIC_TEST Laboratory-based nucleic acid amplification tests (NAATs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05674370
The ClinicalTrials.gov registry entry for NCT05674370 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GRIP Electronic Diagnostic Chip is the first listed.
NCT05674370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05674370 about?
NCT05674370 is a clinical study titled "A Study of the GRIP Influenza and SARS-CoV-2 POC Assays". The purpose of this research is to determine if the use of a new device can accurately detect a virus infection.
What is the current status of trial NCT05674370?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2023-02-01. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT05674370?
The interventions under investigation include: GRIP Electronic Diagnostic Chip (DEVICE), Laboratory-based nucleic acid amplification tests (NAATs) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05674370?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.